Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre

Dig Liver Dis. 2020 Nov;52(11):1248-1249. doi: 10.1016/j.dld.2020.07.021. Epub 2020 Jul 27.

Authors

Fabiana Zingone¹, Andrea Buda², Edoardo Savarino³

Affiliations

¹ Gastroenterology Unit, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.
² Gastroenterology Unit, Department of Oncological Gastrointestinal Surgery, S. Maria del Prato Hospital, Feltre, Italy.
³ Gastroenterology Unit, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy. Electronic address: [email protected].

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
Biological Therapy
COVID-19
Coronavirus Infections*
Humans
Inflammatory Bowel Diseases* / drug therapy
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Uncertainty